单位:[1]Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis & National Clinical Research Center for Digestive Diseases, Beijing 100050, China临床科室国家中心肝病分中心首都医科大学附属北京友谊医院[2]Experimental and Translational Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Tolerance Induction and Organ Protection in Transplantation & National Clinical Research Center for Digestive Diseases, Beijing 100050, China医技科室北京市临床医学研究所实验中心首都医科大学附属北京友谊医院
Extracellular nucleotides, including ATP, are essential regulators of liver function and serve as danger signals that trigger inflammation upon injury. Ectonucleotidases, which are expressed by liver-resident cells and recruited immune cells sequentially hydrolyse nucleotides to adenosine. The nucleotide/nucleoside balance orchestrates liver homeostasis, tissue repair, and functional restoration by regulating the crosstalk between liver-resident cells and recruited immune cells. In this review, we discuss our current knowledge on the role of purinergic signals in liver homeostasis, restriction of inflammation, stimulation of liver regeneration, modulation of fibrogenesis, and regulation of carcinogenesis. Moreover, we discuss potential targeted therapeutic strategies for liver diseases based on purinergic signals involving blockade of nucleotide receptors, enhancement of ectonucleoside triphosphate diphosphohydrolase activity, and activation of adenosine receptors. (C) 2020 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870399, 81770598]; National Science and Technology Major Special Project for New Drug Development [2018ZX09201016]
第一作者单位:[1]Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis & National Clinical Research Center for Digestive Diseases, Beijing 100050, China
通讯作者:
通讯机构:[1]Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis & National Clinical Research Center for Digestive Diseases, Beijing 100050, China[2]Experimental and Translational Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Tolerance Induction and Organ Protection in Transplantation & National Clinical Research Center for Digestive Diseases, Beijing 100050, China[*1]Experimental and Translational Research Center, Beijing Friendship Hospital, Yong An Road No.95, Xi Cheng District, Beijing 100050, China.[*2]Beijing Friendship Hospital, Yong An Road No.95, Xi Cheng District, Beijing 100050, China
推荐引用方式(GB/T 7714):
Wang Ping,Jia Jidong,Zhang Dong.Purinergic signalling in liver diseases: Pathological functions and therapeutic opportunities[J].JHEP REPORTS.2020,2(6):doi:10.1016/j.jhepr.2020.100165.
APA:
Wang Ping,Jia Jidong&Zhang Dong.(2020).Purinergic signalling in liver diseases: Pathological functions and therapeutic opportunities.JHEP REPORTS,2,(6)
MLA:
Wang Ping,et al."Purinergic signalling in liver diseases: Pathological functions and therapeutic opportunities".JHEP REPORTS 2..6(2020)